Drug support firm Malin on fresh hunt for new CEO
The chief executive of Malin Corporation is to leave the company a year after taking the job. The State-backed investment company is active in the drug development and life sciences sectors. Adrian Howd, who stepped up from being Malin’s chief investment officer to become CEO last October, will leave the company on October 26.





